Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v2.4.1.9
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Assets    
Financing receivables $ 552,706us-gaap_LongTermInvestmentsAndReceivablesNet $ 347,871us-gaap_LongTermInvestmentsAndReceivablesNet
Financing receivables held-for-sale 62,275us-gaap_LoansReceivableHeldForSaleNet 24,758us-gaap_LoansReceivableHeldForSaleNet
Investments available-for-sale 27,273us-gaap_AvailableForSaleSecurities 3,213us-gaap_AvailableForSaleSecurities
Investments held-to-maturity   91,964us-gaap_HeldToMaturitySecurities
Real estate 90,907us-gaap_RealEstateInvestments  
Real estate related intangible assets 23,058us-gaap_FiniteLivedIntangibleAssetsNet  
Equity method investment in affiliate 143,903us-gaap_EquityMethodInvestments  
Cash and cash equivalents 58,199us-gaap_CashAndCashEquivalentsAtCarryingValue 31,846us-gaap_CashAndCashEquivalentsAtCarryingValue
Restricted cash and cash equivalents 11,943us-gaap_RestrictedCashAndCashEquivalents 49,865us-gaap_RestrictedCashAndCashEquivalents
Other assets 39,993us-gaap_OtherAssets 21,915us-gaap_OtherAssets
Total Assets 1,010,257us-gaap_Assets 571,432us-gaap_Assets
Liabilities and Equity    
Accounts payable, accrued expenses, and other 11,408us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent 9,095us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
Deferred funding obligations 88,288us-gaap_ContractualObligation 74,675us-gaap_ContractualObligation
Credit facility 315,748us-gaap_LineOfCredit 77,114us-gaap_LineOfCredit
Asset-backed nonrecourse notes (secured by assets of $247.8 million and $109.5 million, respectively) 208,246us-gaap_NonRecourseDebt 100,081us-gaap_NonRecourseDebt
Other nonrecourse debt (secured by financing receivables of $108.4 million and $156.4 million, respectively) 112,525hasi_OtherNonRecourseDebt 159,843hasi_OtherNonRecourseDebt
Total Liabilities 736,215us-gaap_Liabilities 420,808us-gaap_Liabilities
Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding      
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 26,377,111 and 15,892,927 shares issued and outstanding, respectively 264us-gaap_CommonStockValue 159us-gaap_CommonStockValue
Additional paid in capital 293,635us-gaap_AdditionalPaidInCapitalCommonStock 160,120us-gaap_AdditionalPaidInCapitalCommonStock
Retained deficit (25,006)us-gaap_RetainedEarningsAccumulatedDeficit (13,864)us-gaap_RetainedEarningsAccumulatedDeficit
Accumulated other comprehensive income 406us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax 110us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
Non-controlling interest 4,743us-gaap_MinorityInterest 4,099us-gaap_MinorityInterest
Total Equity 274,042us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 150,624us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Total Liabilities and Equity $ 1,010,257us-gaap_LiabilitiesAndStockholdersEquity $ 571,432us-gaap_LiabilitiesAndStockholdersEquity